Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evacetrapib Dose Response in Japanese Subjects
NCT01375075Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jun 2011
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of evacetrapib in dyslipidemia, sponsored by Eli Lilly and Company. Started Jun 2011; status: completed.
02
Drugs
evacetrapib
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT01375075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01375075.